Publications by authors named "Marc Ernstoff"

Claim this Profile
T
Tumor miRNA Signatures Associate with Outcomes of Patients with Stage II/III Melanoma.
Jennifer M Wiggins, Qiao Zhang, Yian Zhang, Fatemeh Vand-Rajabpour, Douglas Hanniford, Marc S Ernstoff

Clin Cancer Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Society for Immunotherapy of Cancer: Standards for Reporting of Multiplex Immunohistochemistry/Immunofluorescence Assays (STORMI).
Sam Sater, Carlo B Bifulco, Jaime Rodriguez-Canales, Joe Yeong, Guray Akturk, Marc S Ernstoff

J Immunother Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inherited mitochondrial genetics as a predictor of immune checkpoint inhibition efficacy in melanoma.
Kelsey R Monson, Robert Ferguson, Joanna E Handzlik, Leah Morales, Jiahan Xiong, Marc S Ernstoff

Nat Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scaffold-Free Functional Deconvolution Identifies Clinically Relevant Metastatic Melanoma EV Biomarkers.
Shin-La Shu, Shawna Benjamin-Davalos, Xue Wang, Eriko Katsuta, Megan Fitzgerald, Marc S Ernstoff

Cancers (Basel)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Analysis of Intracranial Response Assessment Criteria in Patients With Melanoma Brain Metastases Treated With Combination Nivolumab + Ipilimumab in CheckMate 204.
Raymond Y Huang, Gilbert Youssef, Thomas Nelson, Patrick Y Wen, Peter Forsyth, Marc S Ernstoff

J Clin Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune and Metabolic Reprogramming Induced by Paclitaxel, Capecitabine and Eribulin in Breast Cancer: Insights into Therapeutic Targets.
Hua-Hsin Hsiao, Riya Patel, Pawel Kalinski, Kazuaki Takabe, Marc S Ernstoff

Breast Cancer (Dove Med Press)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA Methylation Classes of Stage II and III Primary Melanomas and Their Clinical and Prognostic Significance.
Kathleen Conway, Sharon N Edmiston, Amanda Vondras, Allison Reiner, David L Corcoran, Marc S Ernstoff

JCO Precis Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nemvaleukin alfa, a modified interleukin-2 cytokine, as monotherapy and with pembrolizumab in patients with advanced solid tumors (ARTISTRY-1).
Ulka N Vaishampayan, Jameel Muzaffar, Ira Winer, Seth D Rosen, Christoper J Hoimes, Marc S Ernstoff

J Immunother Cancer· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Checkpoint Inhibitor Therapy and Associations with Clonal Hematopoiesis.
Abhay Singh, Nuria Mencia Trinchant, Rahul Mishra, Kirti Arora, Smit Mehta, Marc S Ernstoff

Int J Mol Sci· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving Accuracy of Somatic Mutation Profiling in Large Epidemiologic Studies: Addressing Cases without Matched Normal Samples.
Arshi Arora, Li Luo, Caroline E Kostrzewa, Allison Reiner, Venkatraman Seshan, Marc S Ernstoff

bioRxiv· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of artificial intelligence chatbots in clinical management of immune-related adverse events.
Hannah Burnette, Aliyah Pabani, Mitchell S von Itzstein, Benjamin Switzer, Run Fan, Marc S Ernstoff

J Immunother Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous human preclinical modeling of melanoma interpatient clinical responses to immunotherapeutics.
Yee Peng Phoon, Jared E Lopes, Lukas W Pfannenstiel, Claudia Marcela Diaz-Montero, Ye F Tian, Marc S Ernstoff

J Immunother Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 1st-3rd, 2022-Naples, Italy).
Paolo A Ascierto, Sanjiv S Agarwala, Allison Betof Warner, Marc S Ernstoff, Bernard A Fox

J Transl Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methylation of nonessential genes in cutaneous melanoma - Rule Out hypothesis.
Ivan P Gorlov, Kathleen Conway, Sharon N Edmiston, Eloise A Parrish, Honglin Hao, Marc S Ernstoff

Melanoma Res· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of alternating sunitinib and temsirolimus therapy in patients with metastatic renal cell carcinoma.
Dylan B Ness, Darcy B Pooler, Steven Ades, Brian J Highhouse, Bridget M Labrie, Marc S Ernstoff

Cancer Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluctuations in Gut Microbiome Composition During Immune Checkpoint Inhibitor Therapy.
Joy Sarkar, Eduardo Cortes Gomez, Takaaki Oba, Hongbin Chen, Grace K Dy, Marc S Ernstoff

World J Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
InterMEL: An international biorepository and clinical database to uncover predictors of survival in early-stage melanoma.
Irene Orlow, Keimya D Sadeghi, Sharon N Edmiston, Jessica M Kenney, Cecilia Lezcano, Marc S Ernstoff

PLoS One· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathway Alterations in Stage II/III Primary Melanoma.
Caroline E Kostrzewa, Li Luo, Arshi Arora, Venkatraman E Seshan, Marc S Ernstoff

JCO Precis Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the secreted RGDKGE collagen fragment reduces PD‑L1 by a proteasome‑dependent mechanism and inhibits tumor growth.
Jennifer M Caron, Xianghua Han, Christine W Lary, Pradeep Sathyanarayana, Scot C Remick, Marc S Ernstoff

Oncol Rep· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Landscape of mutations in early stage primary cutaneous melanoma: An InterMEL study.
Li Luo, Ronglai Shen, Arshi Arora, Irene Orlow, Klaus J Busam, Marc S Ernstoff

Pigment Cell Melanoma Res· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 2nd - 4th, 2021, Italy).
Paolo A Ascierto, Sanjiv S Agarwala, Christian Blank, Corrado Caracò, Richard D Carvajal, Marc S Ernstoff

J Transl Med· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maximizing the value of phase III trials in immuno-oncology: A checklist from the Society for Immunotherapy of Cancer (SITC).
Michael B Atkins, Hamzah Abu-Sbeih, Paolo A Ascierto, Michael R Bishop, Daniel S Chen, Marc S Ernstoff

J Immunother Cancer· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Augmenting antibody response to EGF-depleting immunotherapy: Findings from a phase I trial of CIMAvax-EGF in combination with nivolumab in advanced stage NSCLC.
Rachel Evans, Kelvin Lee, Paul K Wallace, Mary Reid, Jason Muhitch, Marc Ernstoff

Front Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing Metastatic Melanoma in 2022: A Clinical Review.
Benjamin Switzer, Igor Puzanov, Joseph J Skitzki, Lamya Hamad, Marc S Ernstoff

JCO Oncol Pract· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of vedolizumab and infliximab treatment for immune-mediated diarrhea and colitis in patients with cancer: a two-center observational study.
Fangwen Zou, David Faleck, Anusha Thomas, Jessica Harris, Deepika Satish, Marc S Ernstoff

J Immunother Cancer· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis